These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21839241)

  • 1. Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up.
    Álamo JM; Bernal C; Barrera L; Marín LM; Suárez G; Serrano J; Gómez MA; Padillo FJ
    Transplant Proc; 2011; 43(6):2230-2. PubMed ID: 21839241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Heneghan MA; Zolfino T; Muiesan P; Portmann BC; Rela M; Heaton ND; O'grady JG
    Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caroli's disease and orthotopic liver transplantation.
    Habib S; Shakil O; Couto OF; Demetris AJ; Fung JJ; Marcos A; Chopra K
    Liver Transpl; 2006 Mar; 12(3):416-21. PubMed ID: 16498655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F; Harms J; Bartels M; Uhlmann D; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
    Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
    Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma.
    Dudek K; Kornasiewicz O; Remiszewski P; Kobryń K; Ziarkiewicz-Wróblewska B; Górnicka B; Zieniewicz K; Krawczyk M
    Transplant Proc; 2009 Oct; 41(8):3135-7. PubMed ID: 19857695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.